Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This research study is a Phase II clinical trial to test the efficacy of Olaparib in adult
participants with recurrent/metastatic Ewing's Sarcoma following failure of prior
chemotherapy.